July 26, 2012
July 26, 2012 —
…a cure for cancer stems from personal experience. His father battled prostate cancer and ultimately lost his life to pancreatic cancer. As a professor of pharmacology, chemistry and biochemistry at UC San Diego and a Howard Hughes Medical Institute investigator, he has worked to develop a novel way to image…
October 18, 2017
October 18, 2017 —
Modeling the interplay between neurons and astrocytes derived from children with Autism Spectrum Disorder (ASD), researchers at University of California San Diego School of Medicine, with colleagues in Brazil, say innate inflammation in the latter appears to contribute to neuronal dysfunction in at least some forms of the disease.
February 16, 2012
February 16, 2012 —
In a step toward deciphering the “splicing code” of the human genome, researchers at the University of California, San Diego School of Medicine have comprehensively analyzed six of the more highly expressed RNA binding proteins collectively known as heterogeneous nuclear ribonucleoparticle (hnRNP) proteins.
September 4, 2012
September 4, 2012 —
…the UC San Diego Stem Cell Research program and funded by the California Institute for Regenerative Medicine (CIRM) looks at an important RNA binding protein called LIN28, which is implicated in pluripotency and reprogramming as well as in cancer and other diseases. According to the researchers, their study – published…
June 10, 2024
June 10, 2024 —
Researchers have developed — and shared — a process for creating brain cortical organoids — essentially miniature artificial brains with functioning neural networks
December 5, 2017
December 5, 2017 —
Using a database of multiple myeloma patient samples and information, researchers at University of California San Diego School of Medicine found that high ADAR1 levels correlate with reduced survival rates. They also determined that blocking the enzyme reduces multiple myeloma regeneration in experimental models derived from patient cancer cells.
January 20, 2021
January 20, 2021 —
UC San Diego study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma.
August 19, 2013
August 19, 2013 —
UC San Diego faculty members have garnered three of 15 Multidisciplinary University Research Initiative awards granted by the Department of Defense this year. The MURI program supports research by teams of investigators that encompass several traditional science and engineering disciplines to accelerate research progress.
December 21, 2015
December 21, 2015 —
…the proliferation and spread of chronic lymphocytic leukemia (CLL) cells, the most common form of blood cancer in adults.
September 25, 2013
September 25, 2013 —
A team of cancer researchers at the University of California, San Diego has identified the existence of precursor cells in early prostate cancers. These cells are resistant to androgen-deprivation therapy, and may drive the subsequent emergence of recurrent or metastatic prostate cancer.